However, further studies are needed to deepen our understanding of SOX2 and other embryonic factors during mammary tumorigenesis and larger numbers of prospectively collected samples should be screened before proposing SOX2 as a predictor of lymphonodal status in breast cancer. The gene discussed is SOX2; the disease is breast cancer.